Whole Genome Sequencing (WGS) test now available through Foundation Medicine’s FlexOMx Lab™ to support biomarker discovery and drug development across cardiometabolic, immunologic and neurologic ...
Dataset encompasses ConcertAI’s full network of industry partners, representing nearly half a million patients Applications span entire drug development lifecycle, accelerating precision oncology ...
ST. LOUIS, MO, UNITED STATES, February 23, 2026 /EINPresswire.com/ — On February 28, communities around the world will recognize Rare Disease Day, a global movement ...
BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced that it has expanded its immunohistochemistry (IHC) test offerings to ...
"As biopharmaceutical pipelines expand targeted therapies beyond the traditional oncology space and into different areas of medicine, the demand for quality germline data has never been greater,” said ...
Foundation Medicine, Inc., a global precision medicine company, today announced the launch of its Whole Genome Sequencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results